AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇼

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE in Zimbabwe

8 products registered with MCAZ 8 active

Brand / ProductReg. No.HolderStatusExpires
METRICASON 250/25MCG
AEROSOL; INHALATION
2025/22.1.4/6880COSPHARM INVESTMENTS PVT LTDactive24 Feb 2030
METRICASON 50/25MCG
AEROSOL; INHALATION
2025/22.1.4/6878COSPHARM INVESTMENTS PVT LTDactive24 Feb 2030
METRICASONE 125/25MCG
AEROSOL; INHALATION
2025/22.1.4/6879COSPHARM INVESTMENTS PVT LTDactive24 Feb 2030
COMBIWAVE SF 250
INHALATION
2016/22.1.14/5270GLENMARK PHARMACEUTICAL LIMITEDactive6 May 2029
COMBIWAVE SF
INHALATION
2016/22.1.4/5269GLENMARK PHARMACEUTICAL LIMITEDactive6 May 2029
AVASALF 250/50
INHALATION
2020/22.1.4/5973INNOVATA PHARMACEUTICALS LTDactive31 Dec 2027
AVASALF 100/50
INHALATION
2020/22.1.4/5972INNOVATA PHARMACEUTICALS LTDactive31 Dec 2027
AVASALF 500/50
INHALATION
2020/22.1.4/5974INNOVATA PHARMACEUTICALS LTDactive31 Dec 2027

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEMCAZ Registration Details

MCAZ (Zimbabwe) has 8 registered products containing FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE, of which 8 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.